Skip to main content
SpringerLink
Log in

Rationale for Increasing the Starting Dose of Simvastatin

  • Correspondence
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Isaacsohn J, Tobert JA, Johnson-Levonas AO, et al. Addressing a treatment gap: rationale for increasing the starting dose of simvastatin in hypercholesterolaemic patients. Clin Drug Invest 2002; 22(5): 291–301

    Article  CAS  Google Scholar 

  2. Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001 Apr 4; 285(13): 1711–8

    Article  PubMed  CAS  Google Scholar 

  3. Hilleman DE, Phillips JO, Mohiuddin SM, et al. A population based treat-to-target pharmacoeconomic analysis of HMG-CoA reductase inhibitors in hypercholesterolemia. Clin Ther 1999; 21: 536–62

    Article  PubMed  CAS  Google Scholar 

  4. Lucas BD Jr, Sanoski CA, Ito MK, et al. Multicenter treat-to-target cost-effectiveness evaluation of HMG-CoA reductase inhibitor monotherapy. J Appl Res 2002; 2(2): 97–113

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Charleston Area Medical Center, Health Education and Research Institute and West Virginia University, Charleston, West Virginia, USA

    B. Daniel Lucas, Abdul-Karim Elhabyan & Kristy H. Lucas

Authors
  1. B. Daniel Lucas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abdul-Karim Elhabyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kristy H. Lucas
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lucas, B.D., Elhabyan, AK. & Lucas, K.H. Rationale for Increasing the Starting Dose of Simvastatin. Clin. Drug Investig. 22, 639 (2002). https://doi.org/10.2165/00044011-200222090-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-200222090-00009

Keywords

Search

Navigation